BioCentury
ARTICLE | Clinical News

Thalomid thalidomide: Began Pilot Testing

March 29, 1999 8:00 AM UTC

Celgene Corp. (CELG), Warren, N.J. Product: Thalomid thalidomide Business: Cancer Therapeutic category: Angiogenesis Target: Unknown Description: Thalidomide Indication: Treat non-small cell lung can...